Risk assessment with gut microbiome and metabolite markers in NAFLD development

Leung, Howell, Long, Xiaoxue, Ni, Yueqiong, Qian, Lingling, Nychas, Emmanouil, Siliceo, Sara Leal, Pohl, Dennis, Hanhineva, Kati, Liu, Yan, Xu, Aimin, Nielsen, Henrik B., Belda, Eugeni, Clément, Karine, Loomba, Rohit, Li, Huating, Jia, Weiping, Panagiotou, Gianni·2022·Science Translational Medicine
DOI 10.1126/scitranslmed.abk0855

Cited by (152)

Items 101–152 of 152

  1. Plasma proteomics framework predicts metabolic dysfunction-associated steatotic liver disease up to 16 years before onset
    Shiyi Yu, Chunling Chen, Jing Feng, Qinming Li, Shuo Chen, Ruijie Zeng, Dongling Luo, Wentao Huang, Kexin Zhang, Yuying Ma et al. · 2026 · Nature Aging
  2. Hub Genes Involved in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma
    Baiyi Liu, Xiaoxiao Wang, Nan Wu, Feng Liu, Huiying Rao · 2024 · Current Medicinal Chemistry
  3. Liver Sinusoidal Endothelium: The Hidden Interface in the Gut–Liver Axis in Metabolic Dysfunction-Associated Steatotic Liver Disease?
    Ting Chen, Aldo Grefhorst, Adriaan Georgius Holleboom · 2025 · Lipidology
  4. Identifying Causal Relations between Gut Microbiome, Metabolic Dysfunction-Associated Fatty Liver Disease and the Novel Mediators of Blood Metabolites
    Xinghao Yi, Haoxue Zhu, Mengyu He, Ling Zhong, Shan Gao, Ming Li · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Microbial oral-gut translocation in advanced chronic liver disease is linked to exacerbation of intestinal barrier dysfunction and hepatic fibrosis
    Shen Jin, Aurélie Cenier, Daniela Wetzel, Bethlehem Arefaine, Mar Moreno‐Gonzalez, Marilena Stamouli, Merianne Mohamad, Mariia Lupatsii, Emilio García Ríos, Sunjae Lee et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  6. Clinical Features and Plasma Metabolites Analysis in Obese Chinese Children With Nonalcoholic Fatty Liver Disease
    Xiaoxiao Liu, Shifeng Ma, Jing Li, Mingkun Song, Yun Li, Yingyi Qi, Fei Liu, Zhongze Fang, Rongxiu Zheng · 2025 · Journal of the Endocrine Society
  7. An Overview of Non-alcoholic Fatty Liver Diseases (NAFLD)
    Ju‐Seop Kang, Hyun-Jin Kim, So-Jung Lim, Sang‐Won Lee, Inyoung Hwang · 2025 · IntechOpen eBooks
  8. The machine learning prediction model of non-alcoholic fatty liver; the role of hydrogen and methane breath tests
    Sanggwon An, E.Y. Cho, Junho Hwang, Hyunseong Yang, Jungho Hwang, Kyu-Sik Shin, Kyu-Nam Kim, Wooyoung Lee · 2025 · Journal of Breath Research
  9. Potential mechanisms of natural metabolites and botanical drugs foumulae for the treatment of non-alcoholic fatty liver disease: targeting the gut microbiota to modulate the immune system
    Yutian Zhang, Lang Liu, Ruihao Song, Ziyi Qu, Tianlin Wang, Lei Liang, Shunhua Wang, Shuzhi Zhang, Huizhen Li, Hong Wang · 2025 · Frontiers in Pharmacology
  10. Mycobiome dysbiosis and genetic predisposition to elevated IL-17A contribute to fibrosis in MASLD
    Nadja Thielemann, Sara Leal Siliceo, Monika Rau, Annika Schöninger, Nathalie Reus, Alexander Maximilian Aldejohann, Aia Shehata, Isabell S. Behr, Natalie Eva Nieuwenhuizen, Michaela Herz et al. · 2025 · JHEP Reports
  11. Integrated metabolomics and metagenomics analysis identifies a unique signature characterizing metabolic syndrome
    Sivaporn Wannaiampikul, Brian Lee, Jiarui Chen, Kacey J. Prentice, R. Ayansola, Aimin Xu, Sylvia Santosa, Kostas Pantopoulos, Gary Sweeney · 2026 · The Journal of Nutritional Biochemistry
  12. Artificial intelligence for metabolic dysfunction-associated steatotic liver disease diagnosis: A systematic review
    Ruijuan Wang, Chang Liu, Mei Xue, Jun Qian, Yue Hu · 2026 · Computers in Biology and Medicine
  13. Biomarkers for early identification of metabolic dysfunction-associated steatotic liver disease (MASLD): a narrative review
    Aleksandra N. Klisic, Ratko Tomašević, Slavko Đjurašković, Filiz Mercantepe, Ana Ninić · 2026 · Archives of Medical Science
  14. Gut Microbiota in NAFLD/MASLD: Functional Dysbiosis and the Gut–Liver Axis in Disease Progression
    Marica Colella, Rossana Notaristefano, Maria Tragni, Manuela Mandorino · 2026 · Livers
  15. Nonalcoholic fatty liver disease associated with obesity and type 2 diabetes and gut dysbiosis
    T. М. Bentsa · 2024 · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
  16. Potential contribution of GST-T1 and GST-M1 polymorphisms in the onset of hepatic steatosis: from radiological to molecular and medico-legal analyses
    Vincenzo Cianci, Cristina Mondello, Gennaro Baldino, Giovanna Spatari, Angela Alibrandi, Alessio Cianci, Annalisa Cracò, Patrizia Gualniera, Alessio Asmundo, Michele Gaeta et al. · 2024 · Frontiers in Gastroenterology
  17. New Insights into Nutrition and Gut–Liver Axis: A Focus on Non-Alcoholic Fatty Liver Disease
    Ildefonso Rodríguez‐Ramiro · 2023 · Nutrients
  18. Mycobiome Dysbiosis and Genetic Predisposition for Elevated IL-17A Drive Fibrosis in MASLD
    Nadja Thielemann, Sara Leal Siliceo, Monika Rau, Annika Schöninger, Nathalie Reus, Alexander Maximilian Aldejohann, Aia Shehata, Isabell S. Behr, Natalie Eva Nieuwenhuizen, Michaela Herz et al. · 2024 · medRxiv
  19. Accurate prediction of HCC risk after SVR in patients with Hepatitis C cirrhosis based on longitudinal data
    Yanzheng Zou, Ming Yue, Linna Jia, Yifan Wang, Hongbo Chen, A‐Mei Zhang, Xueshan Xia, Wei Liu, Rongbin Yu, Sheng Yang et al. · 2023 · Research Square
  20. Etiopatogenia/fisiopatología de la enfermedad del hígado graso no alcohólica (NAFLD)
    Manuel Antonio Ruiz Quintero, Jaime Navarro Pérez · 2023 · Diabetes práctica
  21. Probiotic potential and antimicrobial activity of Bacteroidales strains to fight fatty liver disease
    Diego García-Morena · 2024
  22. Pathogenesis of NAFLD/NASH
    Juliane I. Beier, Valentina Medici, Sean Paul Spencer, Weiguo Fan, Natalie Julia Torok · 2024 · Elsevier eBooks
  23. La sfida della prevenzione in medicina interna: a call for action | The challenge of prevention in internal medicine: a call for action
    Francesco Dentali, Sara Rotunno · 2024 · Italian Journal of Medicine
  24. SINTESIS SENYAWA METABOLIT OLEH MIKROBIOTA SALURAN CERNA DAN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): TINJAUAN PADA SCFA DAN BCAA
    Hainun Zariyah, Adriyan Pramono · 2025 · Journal of Nutrition College
  25. Biostimulant-Induced Phosphorus Activation in Soils: Mechanisms and Efficacy of Polyglutamic and Humic Acids
    Mengyuan Yang, Jikang Su, Huilin Lv, Jia Huixin, Yun Wenrong, Liu Jiangang, Gengmao Zhao · 2025 · SSRN Electronic Journal
  26. Metabolic dysfunction–associated steatotic liver disease in individuals with type 2 diabetes mellitus and diabetic foot ulcers: prevalence and associated factors
    Hüseyin Karaaslan, Ensar Gazi Göçer, Ferit Doğan · 2025 · Journal of Diabetes & Metabolic Disorders
  27. Additional file 1 of Accurate prediction of HCC risk after SVR in patients with hepatitis C cirrhosis based on longitudinal data
    Yanzheng Zou, Yue, Ming, Linna Jia, Wang, Yifan, Chen, Hongbo, Zhang, Amei, Xia, Xueshan, Liu, Wei, Yu, Rongbin, Yang, Sheng et al. · 2023 · Figshare
  28. Additional file 4 of Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults
    Zeng, Fangfang, Su, Xin, Xinxiu Liang, Liao, Minqi, Zhong, Haili, Xu, Jinjian, Wanglong Gou, Zhang, Xiangzhou, Luqi Shen, Zheng, Ju-Sheng et al. · 2024 · Figshare
  29. Additional file 2 of Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults
    Zeng, Fangfang, Su, Xin, Xinxiu Liang, Liao, Minqi, Zhong, Haili, Xu, Jinjian, Wanglong Gou, Zhang, Xiangzhou, Luqi Shen, Zheng, Ju-Sheng et al. · 2024 · Figshare
  30. Additional file 5 of Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults
    Zeng, Fangfang, Su, Xin, Xinxiu Liang, Liao, Minqi, Zhong, Haili, Xu, Jinjian, Wanglong Gou, Zhang, Xiangzhou, Luqi Shen, Zheng, Ju-Sheng et al. · 2024 · Figshare
  31. Additional file 1 of Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults
    Zeng, Fangfang, Su, Xin, Xinxiu Liang, Liao, Minqi, Zhong, Haili, Xu, Jinjian, Wanglong Gou, Zhang, Xiangzhou, Luqi Shen, Zheng, Ju-Sheng et al. · 2024 · Figshare
  32. Additional file 3 of Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults
    Zeng, Fangfang, Su, Xin, Xinxiu Liang, Liao, Minqi, Zhong, Haili, Xu, Jinjian, Wanglong Gou, Zhang, Xiangzhou, Luqi Shen, Zheng, Ju-Sheng et al. · 2024 · Figshare
  33. The Current Landscape of Microbial Biomarkers in Gastrointestinal Disease
    Sohn G. Kim, Matthew Y. Zhao, Christine Lam, Jonathan P. Jacobs · 2025 · Gastroenterology Clinics of North America
  34. Harnessing the power of the gut microbiome: a review of supplementation diagnosis and therapy for liver cirrhosis
    Yuanqing Zhu, Wenkang Gao, Mingjian Cheng, Xuyang Li, Kailin Cai, Liuying Chen, Huikuan Chu · 2026 · Cellular and Molecular Life Sciences
  35. The role of Traditional Chinese Medicine in the management of liver disease: targeting gut microbiome
    Qi Zhang, Hongkun Li, Fei Yu, Mengmeng Gao, Yang Wang, Siyu Xin, Jie Yang, Zhiwei Wang, Lujie Xiang, Qingjing Ru et al. · 2026 · Chinese Medicine
  36. Raspberry aqueous extract ameliorates MAFLD in mice by regulating gut microbiota and purine metabolism
    Yanyan Gao, Nian Liu, Huaxin Wei, Tianchi Sun, Fangying Xu, Le Chen, Jiannan Qiu, Xiaobing Dou · 2026 · Frontiers in Nutrition
  37. Integrated Metagenomics and Metabolomics Studies Reveal Core Bacterial Guild Regulating Carbohydrate Metabolism in Pediatric MASLD
    Jiating Huang, Xuelian Zhou, H L Wang, Ana Liu, JUNFEN FU, G P Dong, Ying Shen, Wenqing Xiang, Jeffrey B. Schwimmer, Gang Yu et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  38. IMCP-net: An imbalance-aware multi-modal contrastive framework for metabolic pathway prediction on NAFLD
    Jing Liu, Xinwei Chen, Kun Li, Cuiju Luan, Xiao Guan · 2026 · Computational Biology and Chemistry
  39. Maternal-Infant Gut Microbiota Transmission and the Early Origins of Metabolic Liver Diseases: Mechanisms and Interventional Opportunities
    Xinrui Meng, Xueping Wu, Han Sun, Jing Cong, Yuchao Gu · 2026 · Nutrition Reviews
  40. Comprehensive Complete-Genome Analysis of Lactobacillaceae and Bifidobacteriaceae Reveals Strain-Specific Metabolic Interactions in Chinese Gut Microbiota
    Xin Tong, Hewei Liang, Yu Tian, Xinyu Yang, Ya Wang, Haoyu Wang, Yuzheng Gu, Zhihui Ma, Wenrui Su, Yanhong Liu et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  41. Bifidobacterium longum alleviation of metabolic dysfunction-associated steatotic liver disease: A multi-omics landscape of microbiota and metabolome reconfiguration
    Juan Li, Jing Ji, Xiaomin Ma, Zhuyan Xu, Leyan Zhou, Yutong Guan, Xiaohong Ling, Xue Jia, Bo Xi, Min Zhao · 2026 · Microbiological Research
  42. Dietary index for gut microbiota, plasma metabolome, and risks of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases
    Mengyu Zhou, Yuqing Deng, Yuxiang Huang, Chao Yu, Xuechen Chen, Qiaoqiao Yang, Yingxin Liao, Shijia Wang, Peiting Zhang, 陈爱兰 et al. · 2026 · Nutrition & Metabolism
  43. Advancements in the study of gut microbiome in disease diagnosis
    Kun Liu, Zhiqiang Huang, Qing Liu · 2026 · Antonie van Leeuwenhoek
  44. Gut microbiota modulates nonalcoholic fatty liver disease (NAFLD) progression via regulation of gluconeogenesis: mechanisms and translational research
    WeiZhou Wang, YunTao Tang, ZiQian Wan, Zhiquan Zhang, Zhouhang Zheng, HuiLong Liu, Qipeng Shu, ShangZe Li · 2026 · Pharmacological Research
  45. Predicting Food Safety Problems Among Catering Service Operators Using Longitudinal Regulatory Data
    Wen-Hui Wang, Yi-Qi Li, Yang Guo, Zi-Wen Zhou, Shao-Jie Peng · 2026 · Journal of Food Protection
  46. Metabolic and Bariatric Surgery as a Therapeutic Option for MASLD: Outcome, Mechanism, and Long-Term Implications
    Martin Reichert, Moritz J. Strowitzki, Christopher Tuffs, Anca‐Laura Amati, Daniar Amin, Sonali Raj, Thilo Sprenger, Andreas Hecker, Martin Schneider · 2026 · Zeitschrift für Gastroenterologie
  47. Beyond Weight Loss: Rethinking Dietary and Lifestyle Interventions for Liver Disease Modification in MASLD
    Abdulrahman Almujaidel, Eman Marzouk · 2026 · Nutrients
  48. Editorial: The gut-liver axis in MASLD: microbiome, metabolism, disease progression and therapeutic pathways
    Zhengyang Bao · 2026 · Frontiers in Medicine
  49. Profiling Gut Microbiome and Metabolites Aids Diagnosis and Prediction of Progression in Mild Cognitive Impairment
    Birong Zhang, Richard Brown, Antony J. Bayer, Joanna Waring, B. Paul Morgan, Julian Roberto Marchesi, You Zhou · 2026 · MedComm
  50. Gut microbiota shaping fatty liver disease progression
    Martyna Wysokińska, Marta Mysza, Aleksandra Uryga, Aleksandra A. Kolodziejczyk · 2026 · Life Science Alliance
  51. From dietary exposure to organ injury: microbiome-mediated biotransformation of food-chain xenobiotics across the gut–liver–kidney axis
    Guolin Li, Yu Xiong, Xixuan Yu, Jiangping Yu, Ruiling Xu · 2026 · Frontiers in Microbiology
  52. Examining the Gastrointestinal Effects of Solnul®, a Prebiotic Resistant Potato Starch: A Replication Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Healthy Adults
    Jason Bush, Izuchukwu Iwuamadi, Edward C. Deehan · 2026 · Nutrients